|
Living Medical Textbook From Projects In Knowledge |
|
| Chapter 1 Overview of Leukemia Release date: October 2009 |
||
| Chapter 2 Lymphoid Leukemia Release date: November 2009 |
||
| Chapter 3 Myeloid Leukemia Release date: December 2009 |
||
|
|
||||||||||||||||
| Chapter 3 – Myeloid Leukemia | ||||||||||||||||
|
||||||||||||||||
|
Activity Goal The goal of this CME/CE activity is to review the major chemotherapeutic regimens used to treat chronic myeloid leukemia and acute myeloid leukemia and provide rationales for the treatment regimens used for particular patient types and disease phases. |
||||||||||||||||
|
Target Audience This activity is designed for hematologists, oncologists, radiation oncologists, family practice/primary care physicians, and other clinicians involved in the management, treatment, and care of patients with leukemia. |
||||||||||||||||
Learning Objectives
|
||||||||||||||||
| top |
||||||||||||||||
|
CME Information: Physicians
Statement of Accreditation Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Projects In Knowledge designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. CE Information: Nurses Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227. This activity is approved for 1.18 nursing contact hour(s). DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN, or PIK endorsement of any commercial product or service. CE Information: Pharmacists  Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This chapter is worth up to 2.00 contact hours (0.2 CEUs). The ACPE Universal Program Number assigned to this knowledge activity is 0052-0000-09-201-H01-P. top |
||||||||||||||||
|
Disclosure Information The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR). Jerald P. Radich, MD, is a consultant for Axis Pharmaceuticals and Novartis Pharmaceuticals Corporation; and received research support from Novartis Pharmaceuticals Corporation. Neil P. Shah, MD, PhD, is consultant for Bristol-Myers Squibb and Novartis Pharmaceuticals Corporation. Stephanie G. Phillips, PhD , has disclosed no significant relationships. Off-Label Statement: This activity includes a discussion of complex treatment regimens, some of which contain agents that may not be FDA approved or that have off-label indications for use in patients with leukemia. Projects In Knowledge’s staff members have no significant relationships to disclose. top |
||||||||||||||||
Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process. The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge. This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
|
||||||||||||||||
|
||||||||||||||||
|
|
|
This independent CME/CE activity is supported by an educational grant from Bristol-Myers Squibb and Novartis Pharmaceuticals Corporation. |
|
|
Release Date: December 10, 2009. Termination Date: December 10, 2010. |
|
Estimated time for completion of this activity: CME: 2.0 hours CE: 1.18 hours CPE: 2.0 hours |
|
CME/CE Instructions To obtain CME/CE credit for this activity:
There is no fee for this activity. |
|
